Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders

Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or "the Company") announces that all
Directors, Edward Taylor, Don Oborowsky, Gilles Gagnon, Glenn Rourke and John
Zupancic, were re-elected to serve for another year at its annual meeting of
shareholders held on June 11, 2014.


All other matters at the shareholders' meeting, namely the appointment of
Auditors and the Re-approval and Ratification of Stock Options Plan, were also
approved by shareholders.


Also, each member of the board and an officer of the Comapny have elected to
exercise 100% of their options that were granted on June 23, 2009.


About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business
activities relate to the development and commercialization of active ingredients
for personal care and cosmetic industries using proprietary technology and
natural, renewable resources. To learn more about Ceapro, visit www.ceapro.com.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Ceapro Inc.
Branko Jankovic
Vice President and CFO
(Edmonton): 780.917.8376
[e-mail]